Heart drug tested to save lives in High-Risk surgery
NCT ID NCT06462313
Summary
This study tested whether adding a heart medication called dobutamine to standard care improves outcomes for patients with severe septic shock who need surgery under general anesthesia. It involved 584 adult surgical patients to see if the drug could help protect the heart and kidneys, potentially reducing complications and death. The goal was to find a better way to support these critically ill patients during a dangerous procedure.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERAL ANESTHESIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310000, China
Conditions
Explore the condition pages connected to this study.